Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.
Summary
S03575 establishes a uterine fibroids awareness and education program within the New York State Department of Health. The department would be required to run an ongoing public awareness campaign focused on the symptoms, diagnosis, and treatment of uterine fibroids, with particular attention to the elevated risk for minority women. It also directs the department to produce and distribute educational materials for health care providers and patients, and to post related information on its website.
The bill further requires the department to periodically review available data and update its educational content as needed. Beginning April 1, 2030, the department must report every three years to the governor, the temporary president of the Senate, and the speaker of the Assembly on implementation and recommendations. The program is contingent on appropriations, meaning it would operate only if funding is provided, and the act takes effect April 1, 2027, with immediate authorization for any needed implementing regulations.
Impact
The bill amends the Public Health Law by adding a new section 267-c, creating a state-run public education and outreach program on uterine fibroids. It does not create a new clinical mandate or insurance requirement; instead, it expands the Department of Health’s informational and reporting responsibilities and authorizes the use of materials produced by public, private, or governmental entities. Its practical effect would be to increase awareness among patients and providers, especially regarding disparities affecting minority women, subject to available appropriations.
Sentiment
The available voting history shows strong bipartisan support and no recorded opposition, with unanimous committee approval and unanimous or near-unanimous floor passage in the Senate. The bill’s framing around women’s health, public education, and health equity appears to have generated broad agreement. No committee transcript was provided, so there is no evidence of substantive opposition in the supplied materials.
Contention
No major points of contention are reflected in the provided record. The only notable policy limitation is that implementation depends on appropriations, which may affect whether and how fully the program is carried out. Otherwise, the bill appears noncontroversial, with the main focus on improving awareness of uterine fibroids and addressing the higher risk faced by minority women.
Same As
Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.
Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.
Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.
Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.
Establishes the statewide fibroid study program to study fibroids, the treatment of fibroids, potential barriers to the access of treatment for fibroids, and differences in symptoms and access to treatment for women of color.
Establishes the statewide fibroid study program to study fibroids, the treatment of fibroids, potential barriers to the access of treatment for fibroids, and differences in symptoms and access to treatment for women of color.